News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Daily News CT Angiography Moves to Forefront in Assessment of Chest Pain in UK Michael O'Riordan December 07, 2016
News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
News Conference News AHA 2016 PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad Michael O'Riordan November 15, 2016
News Conference News AHA 2016 Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery Michael O'Riordan November 15, 2016
News Conference News AHA 2016 Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study Michael O'Riordan November 14, 2016
News Conference News AHA 2016 Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis Michael O'Riordan November 13, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Conference News TCT 2016 TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES Michael O'Riordan November 02, 2016
Presentation TCT 2016 TCT 517: Fractional Flow Reserve Assessment of Coronary Artery Disease in Patients Undergoing TAVI. Presenter: Alan C. Yeung, Tim P. van de Hoef November 01, 2016
News Conference News TCT 2016 ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events Michael O'Riordan November 01, 2016
News Conference News TCT 2016 New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts Yael L. Maxwell October 31, 2016
Presentation TCT 2016 FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu October 31, 2016
Presentation TCT 2016 FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Antonio Colombo October 31, 2016
Presentation TCT 2016 MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth October 31, 2016
Presentation TCT 2016 FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Alexandre Abizaid October 31, 2016
News Conference News TCT 2016 ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI Shelley Wood October 30, 2016
Presentation TCT 2016 ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs IVUS-Guided vs Angio-Guided Stent Implantation in Patients With Coronary Artery Disease Presenter: Gregg W. Stone, Wayne B. Batchelor, Ziad A. Ali October 30, 2016
News Conference News TCT 2016 YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients Michael O'Riordan October 29, 2016
News Opinion Editor's Corner TCT 2016 TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever Shelley Wood October 24, 2016